About: Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020
Creator	Maman, Issaka Adjidossi, Fifonsi Agbobli, Amétépé Assane, Simon-Pierre Dorkenoo, Ameyo Halatoko, Wemboo Koffi, Komlanvi, Gbeasor-5 Komlanvi, Segbeaya Konu, Yao Marcel, Sossinou Prince-David, Mireille Sadio, Arnold Salou, Mounerou Séraphin, Komi Tchankoni, Martin Wateba, Ihou
Source	MedRxiv
abstract	Objective: This survey aims at estimating the prevalence of SARS-CoV-2 in high risk populations in Lomé. Methods: From April 23rd to May 8th 2020, we recruited a sample of participants from five sectors: healthcare, air transport, police, road transport and informal. We collected oropharyngeal swab for direct detection through real time reverse transcription polymerase chain reaction (rRT-PCR), and blood for antibodies detection by serological tests. The overall prevalence (current and past) of infection was defined by positivity for both tests. Results: A total of 955 participants with a median age of 36 (IQR 32-43) were included and 71.6% (n=684) were men. Around 22.1% (n=212) were from the air transport sector, 20.5% (n=196) in the police, and 38.7% (n=370) in the health sector. Seven participants (0.7%, 95% CI: 0.3-1.6%) had a positive rRT-PCR at the time of recruitment and nine (0.9%, 95% CI: 0.4-1.8%) were seropositive for IgM or IgG against SARS-CoV-2. We found an overall prevalence of 1.6% (n=15), 95% CI: 0.9-2.6%. Conclusion: The prevalence of the SARS-CoV-2 infection among high-risk populations in Lomé was relatively low and could be explained by the various measures taken by the Togolese government. Therefore, we recommend targeted screening.
has issue date	2020-08-07(xsd:dateTime)
bibo:doi	10.1101/2020.08.07.20163840
has license	medrxiv
sha1sum (hex)	48c93d2241b2705530f19ed2e36611669799d0a6
schema:url	https://doi.org/10.1101/2020.08.07.20163840
resource representing a document's title	Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020
resource representing a document's body	covid:48c93d2241b2705530f19ed2e36611669799d0a6#body_text
is schema:about of	named entity 'aims' named entity 'Authors' named entity 'SARS-CoV-2' named entity 'high-risk' named entity 'sample size' named entity 'medRxiv' named entity 'preprint' named entity 'preprint' named entity 'preprint' named entity 'preprint' named entity 'peer review' named entity 'China' named entity 'medRxiv' named entity 'preprint' named entity 'preprint' named entity 'preprint' named entity 'medRxiv' named entity 'peer review' named entity 'peer review' named entity 'peer review' named entity 'peer review' named entity 'preprint' named entity 'preprint' named entity 'Sample size' named entity 'preprint' named entity 'pneumonia' named entity 'selection bias' named entity 'preprint' named entity 'preprint' named entity 'peer review' named entity 'margin of error' named entity 'peer review' named entity 'Iceland' named entity 'preprint' named entity 'preprint' named entity 'preprint' named entity 'preprint' named entity 'medRxiv' named entity 'preprint' named entity 'preprint' named entity 'preprint' named entity 'peer review' named entity 'medRxiv' named entity 'peer review' named entity 'peer review' named entity 'preprint' named entity 'preprint' named entity 'preprint' named entity 'peer review' named entity 'medRxiv' named entity 'preprint' named entity 'Lomé' named entity 'Covid-19' named entity 'SARS' named entity 'preprint' named entity 'preprint' named entity 'medRxiv' named entity 'preprint' named entity 'medRxiv' named entity 'Covid-19' named entity 'medRxiv' named entity 'medRxiv' named entity 'SARS-CoV-2' named entity 'doi' named entity 'preprint' named entity 'peer review' named entity 'preprint' named entity 'data collection' named entity 'preprint'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software